BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36631050)

  • 21. [Vascular medicine and foam sclerotherapy for venous malformations].
    Blaise S
    J Med Vasc; 2017 Oct; 42(5):315-319. PubMed ID: 28964390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series.
    Ahmad S; Akhtar FK
    Phlebology; 2019 Jun; 34(5):355-361. PubMed ID: 30336759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Venous Malformations: The Data, Where We Are, and How It Is Done.
    Hage AN; Chick JFB; Srinivasa RN; Bundy JJ; Chauhan NR; Acord M; Gemmete JJ
    Tech Vasc Interv Radiol; 2018 Jun; 21(2):45-54. PubMed ID: 29784122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome of Management of Vascular Malformations of Lip.
    Sohail M; Bashir MM; Ansari HH; Khan FA; Assumame N; Awan NU; Chatha AA
    J Craniofac Surg; 2016 Sep; 27(6):e520-4. PubMed ID: 27607127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous malformations: classification, development, diagnosis, and interventional radiologic management.
    Legiehn GM; Heran MK
    Radiol Clin North Am; 2008 May; 46(3):545-97, vi. PubMed ID: 18707962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilizing immediate preoperative n-BCA in the resection of head and neck venous and lymphatic malformations.
    Puccia R; Staricha K; Carlberg VM; Moe D; Chun R
    Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110388. PubMed ID: 33152979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations.
    Hanif AM; Saunders JA; Hawkins CM; Wojno TH; Kim HJ
    Orbit; 2019 Feb; 38(1):30-36. PubMed ID: 29902086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of major complication following embolo-sclerotherapy for upper and lower extremity vascular malformations.
    Lim CS; Evans N; Kaur I; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J
    Vascular; 2021 Feb; 29(1):69-77. PubMed ID: 32605532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the treatment of congenital vascular malformations using a multidisciplinary approach.
    Lidsky ME; Markovic JN; Miller MJ; Shortell CK
    J Vasc Surg; 2012 Nov; 56(5):1355-62; discussion 1362. PubMed ID: 22999048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-abdominal lymphatic malformation management in light of the updated International Society for the Study of Vascular Anomalies classification.
    Elbaaly H; Piché N; Rypens F; Kleiber N; Lapierre C; Dubois J
    Pediatr Radiol; 2021 May; 51(5):760-772. PubMed ID: 33559726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foot drop after ethanol embolization of calf vascular malformation: a lesson on nerve injury.
    Tay VK; Mohan PC; Liew WK; Mahadev A; Tay KH
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1165-71. PubMed ID: 22956046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin sclerotherapy of a distensible orbital venous malformation without image guidance.
    Chen Y; Choi CJ; Lee BW
    Can J Ophthalmol; 2019 Jun; 54(3):e120-e123. PubMed ID: 31109497
    [No Abstract]   [Full Text] [Related]  

  • 33. Progress about the fibro-adipose vascular anomaly: A review.
    Sun YR; Zou ML; Yuan SM
    Medicine (Baltimore); 2024 Feb; 103(7):e37225. PubMed ID: 38363925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Japanese clinical practice guidelines for vascular anomalies 2017.
    Mimura H; Akita S; Fujino A; Jinnin M; Ozaki M; Osuga K; Nakaoka H; Morii E; Kuramochi A; Aoki Y; Arai Y; Aramaki N; Inoue M; Iwashina Y; Iwanaka T; Ueno S; Umezawa A; Ozeki M; Ochi J; Kinoshita Y; Kurita M; Seike S; Takakura N; Takahashi M; Tachibana T; Chuman K; Nagata S; Narushima M; Niimi Y; Nosaka S; Nozaki T; Hashimoto K; Hayashi A; Hirakawa S; Fujikawa A; Hori Y; Matsuoka K; Mori H; Yamamoto Y; Yuzuriha S; Rikihisa N; Watanabe S; Watanabe S; Kuroda T; Sugawara S; Ishikawa K; Sasaki S
    Pediatr Int; 2020 Mar; 62(3):257-304. PubMed ID: 32202048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined laparoscopic and cystoscopic injection sclerotherapy for bladder venous malformation: a novel technique.
    Sinha CK; Barnacle A; Mushtaq I; Cherian A
    J Pediatr Urol; 2013 Feb; 9(1):e22-4. PubMed ID: 22841403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An integrated multidisciplinary team approach to the management of vascular anomalies: challenges and benefits.
    Sires JD; Williams N; Huilgol SC; Harvey I; Antoniou G; Dawson J
    Pediatr Surg Int; 2020 Oct; 36(10):1149-1156. PubMed ID: 32770386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-flow vascular malformation treatment using ultrasound-guided laser combined with polidocanol sclerotherapy.
    Zhang Y; Zhou P; Li L; Li JL
    J Med Ultrason (2001); 2015 Jul; 42(3):433-5. PubMed ID: 26576799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient radiation exposure from embolo-sclerotherapy of peripheral vascular malformations.
    Giet L; Evans N; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Brookes J; Lim CS
    J Vasc Surg; 2021 May; 73(5):1794-1799. PubMed ID: 33075453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsurgical management of vascular malformation of masseter.
    Jayaraman V; Austin RD; Kannan S
    Indian J Dent Res; 2015; 26(1):96-100. PubMed ID: 25961625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Outcomes and Effects of Ethanol Sclerotherapy on Systemic Coagulation Profile of Patients with Venous Malformation.
    Yu MW; Han YY; Wang Q; Wang M; Chen Y; Yuan SM
    Ann Vasc Surg; 2022 Sep; 85():268-275. PubMed ID: 35395373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.